RoukenBio's in-house SPR experts discuss our custom SPR assay services and answer FAQs!
|
April 9, 2024
|
5 min read
Welcome to our SPR Reflections video series! In each video, one of our in-house SPR experts will cover a different aspect of our custom SPR assay services and answer FAQs. Watch now!
Throughout the drug development life cycle, therapeutics need to be continuously characterised. We can do this using Surface Plasmon Resonance (SPR) assays, which evaluate protein-protein and protein-small molecule interactions during drug discovery and development.
Our in-house, plug-and-play SPR assays are performed using Biacore 8K instruments, ensuring:
In our first video, our Director of Biophysics, Dr Nichole Cerutti talks about the importance of reagent quality in SPR assays.
In the second episode, Dr Sophie Moncrieff covers our SPR assay set ups and customisation options.
Watch Dr Louis Julien discuss the range of Fc receptors that we produce in-house and the reproducibility of our results.
Finally, Dr Sophie Moncrieff discusses how to transfer your SPR binding assay to RoukenBio.
🗓️ Stay informed with our monthly scientific newsletter, published on LinkedIn on the last Wednesday of each month.
These editions bring you the latest in drug development breakthroughs, industry trends, and expert insights from the brilliant minds at RoukenBio.
Subscribe today on LinkedInWith our in-house produced high quality Fcγ and FcRn receptors and two state-of-the-art Biacore 8Ks on site, we offer high throughput and high performance assays, to get the binding data you need while saving you time and money.
Access the technical presentation